ru 24926 has been researched along with morphine in 3 studies
| Studies (ru 24926) | Trials (ru 24926) | Recent Studies (post-2010) (ru 24926) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 30 | 0 | 0 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | ru 24926 (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degryse, M; Fortin, M; Hunt, PF; Petit, F | 1 |
| Kelly, E; Nahorski, SR | 1 |
| Costentin, J; Suaudeau, C | 1 |
3 other study(ies) available for ru 24926 and morphine
| Article | Year |
|---|---|
The dopamine D2 agonists RU 24213 and RU 24926 are also kappa-opioid receptor antagonists.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Dopamine Agents; Guinea Pigs; In Vitro Techniques; Male; Molecular Structure; Morphine; Narcotic Antagonists; Phenethylamines; Pyrrolidines; Rabbits; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1991 |
Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Alprostadil; Animals; Benzazepines; Carbachol; Cholera Toxin; Corpus Striatum; Cyclic AMP; Isoproterenol; Morphine; Phenethylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Receptors, Opioid; Vasoactive Intestinal Peptide | 1986 |
Analgesic effect of the direct D2 dopamine receptor agonist RU 24926 and cross tolerance with morphine.
Topics: Analgesia; Animals; Body Temperature; Dose-Response Relationship, Drug; Drug Tolerance; Locomotion; Male; Mice; Mice, Inbred Strains; Morphine; Naloxone; Phenethylamines; Receptors, Dopamine D2; Time Factors | 1995 |